The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
Did you read that study that came out a couple of years ago, I think it was PNAS, where like a whole host like maybe some 8 or 12 different biomarkers were looked at, some of the ones you just mentioned telomere length and epigenetic signatures? And there was like such a huge variety... like the effects of these different biomarkers looked at in people the same age were so different.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
yes they looked at glycated hemoglobin so hba1c vo2 max triglycerides telomere length senescence a lot of the you know typical biomarkers that are clinically used to like determine health status yes and and um and it was basically found that people you know aged at very different rates based on those biomarkers